Announcement
7 October 2008: Springer Science + Business Media has reached an agreement to acquire the BioMed Central Group of companies (http://www.springer-sbm.de/index.php?id=291&backPID=132&L=0&tx_tnc_news=4970&cHash=b5a2aa41d8).
The BioMed Central Group comprises: BioMed Central Ltd Chemistry Central Ltd PhysMath Central Ltd Genome Biology Ltd Genome Medicine Ltd Sciencenow Ltd Current Controlled Trials Ltd